These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14623959)

  • 1. Delivery of antimicrobials into parasites.
    Samuel BU; Hearn B; Mack D; Wender P; Rothbard J; Kirisits MJ; Mui E; Wernimont S; Roberts CW; Muench SP; Rice DW; Prigge ST; Law AB; McLeod R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14281-6. PubMed ID: 14623959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
    Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
    ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
    McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW
    Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
    Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
    Afanador GA; Muench SP; McPhillie M; Fomovska A; Schön A; Zhou Y; Cheng G; Stec J; Freundlich JS; Shieh HM; Anderson JW; Jacobus DP; Fidock DA; Kozikowski AP; Fishwick CW; Rice DW; Freire E; McLeod R; Prigge ST
    Biochemistry; 2013 Dec; 52(51):9155-66. PubMed ID: 24295325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections.
    Lai BS; Witola WH; El Bissati K; Zhou Y; Mui E; Fomovska A; McLeod R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14182-7. PubMed ID: 22891343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability.
    Paredes-Santos T; Wang Y; Waldman B; Lourido S; Saeij JP
    Front Cell Infect Microbiol; 2019; 9():321. PubMed ID: 31572690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.
    Muench SP; Stec J; Zhou Y; Afanador GA; McPhillie MJ; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Prigge ST; Rice DW; McLeod R
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3551-5. PubMed ID: 23664871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triclosan inhibits the growth of Neospora caninum in vitro and in vivo.
    Zhang H; Liu J; Yang C; Fu Y; Xu J; Liu Q
    Parasitol Res; 2019 Oct; 118(10):3001-3010. PubMed ID: 31486947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.
    Wilkinson C; McPhillie MJ; Zhou Y; Woods S; Afanador GA; Rawson S; Khaliq F; Prigge ST; Roberts CW; Rice DW; McLeod R; Fishwick CW; Muench SP
    Bioorg Med Chem Lett; 2014 Feb; 24(3):911-6. PubMed ID: 24398298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector.
    Tomita T; Mukhopadhyay D; Han B; Yakubu R; Tu V; Mayoral J; Sugi T; Ma Y; Saeij JPJ; Weiss LM
    mBio; 2021 May; 12(3):. PubMed ID: 34006649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Starch Branching Enzyme 1 Is Important for Amylopectin Synthesis and Cyst Reactivation in Toxoplasma gondii.
    Yang J; He Z; Chen C; Zhao J; Fang R
    Microbiol Spectr; 2022 Jun; 10(3):e0189121. PubMed ID: 35446124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase.
    Muench SP; Prigge ST; Zhu L; Kirisits MJ; Roberts CW; Wernimont S; McLeod R; Rice DW
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):604-6. PubMed ID: 16754994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolic acid induces differentiation of Toxoplasma gondii RH strain tachyzoites into bradyzoites and formation of cyst-like structure in vitro.
    Castro-Elizalde KN; Hernández-Contreras P; Ramírez-Flores CJ; González-Pozos S; Gómez de León CT; Mondragón-Castelán M; Mondragón-Flores R
    Parasitol Res; 2018 Feb; 117(2):547-563. PubMed ID: 29308550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin Cs are key for the intracellular survival of the protozoan parasite, Toxoplasma gondii.
    Que X; Engel JC; Ferguson D; Wunderlich A; Tomavo S; Reed SL
    J Biol Chem; 2007 Feb; 282(7):4994-5003. PubMed ID: 17164247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo.
    Zhou Y; Fomovska A; Muench S; Lai BS; Mui E; McLeod R
    Antimicrob Agents Chemother; 2014; 58(3):1789-92. PubMed ID: 24366743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.
    Dubey JP; Lindsay DS; Speer CA
    Clin Microbiol Rev; 1998 Apr; 11(2):267-99. PubMed ID: 9564564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.
    Tipparaju SK; Muench SP; Mui EJ; Ruzheinikov SN; Lu JZ; Hutson SL; Kirisits MJ; Prigge ST; Roberts CW; Henriquez FL; Kozikowski AP; Rice DW; McLeod RL
    J Med Chem; 2010 Sep; 53(17):6287-300. PubMed ID: 20698542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of ribosomal P protein in Toxoplasma gondii and the availability to detect antibody against recombinant protein in toxoplasmosis patients.
    Ahn HJ; Kim S; Nam HW
    Korean J Parasitol; 2003 Jun; 41(2):89-96. PubMed ID: 12815319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.